Sectoral Asset Management Inc. Buys 900 Shares of Humana Inc. (NYSE:HUM)

Sectoral Asset Management Inc. increased its holdings in shares of Humana Inc. (NYSE:HUMFree Report) by 12.3% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 8,225 shares of the insurance provider’s stock after purchasing an additional 900 shares during the period. Humana makes up approximately 1.6% of Sectoral Asset Management Inc.’s holdings, making the stock its 17th largest position. Sectoral Asset Management Inc.’s holdings in Humana were worth $3,765,000 at the end of the most recent quarter.

Other large investors have also made changes to their positions in the company. Dorsey & Whitney Trust CO LLC boosted its position in Humana by 2.6% in the 3rd quarter. Dorsey & Whitney Trust CO LLC now owns 817 shares of the insurance provider’s stock valued at $397,000 after buying an additional 21 shares during the last quarter. First Financial Corp IN grew its holdings in shares of Humana by 7.2% in the 4th quarter. First Financial Corp IN now owns 343 shares of the insurance provider’s stock valued at $157,000 after acquiring an additional 23 shares in the last quarter. Walker Financial Services Inc. grew its holdings in shares of Humana by 3.9% in the 4th quarter. Walker Financial Services Inc. now owns 795 shares of the insurance provider’s stock valued at $364,000 after acquiring an additional 30 shares in the last quarter. Signaturefd LLC grew its holdings in shares of Humana by 1.2% in the 4th quarter. Signaturefd LLC now owns 2,634 shares of the insurance provider’s stock valued at $1,206,000 after acquiring an additional 30 shares in the last quarter. Finally, Brighton Jones LLC increased its position in Humana by 6.8% during the fourth quarter. Brighton Jones LLC now owns 470 shares of the insurance provider’s stock worth $215,000 after buying an additional 30 shares during the last quarter. Institutional investors and hedge funds own 92.38% of the company’s stock.

Humana Stock Performance

Shares of Humana stock traded down $3.63 during mid-day trading on Friday, hitting $351.80. 875,933 shares of the stock were exchanged, compared to its average volume of 1,496,934. Humana Inc. has a 12 month low of $298.61 and a 12 month high of $530.54. The company has a 50-day simple moving average of $332.50 and a 200 day simple moving average of $362.56. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.67 and a current ratio of 1.67. The company has a market capitalization of $42.39 billion, a P/E ratio of 21.91, a P/E/G ratio of 2.09 and a beta of 0.53.

Humana (NYSE:HUMGet Free Report) last issued its quarterly earnings results on Wednesday, April 24th. The insurance provider reported $7.23 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.12 by $1.11. Humana had a net margin of 1.82% and a return on equity of 17.76%. The company had revenue of $29.61 billion during the quarter, compared to analyst estimates of $28.52 billion. During the same quarter last year, the business posted $9.38 EPS. Humana’s quarterly revenue was up 10.7% compared to the same quarter last year. Sell-side analysts anticipate that Humana Inc. will post 16 earnings per share for the current fiscal year.

Humana Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, July 26th. Investors of record on Friday, June 28th will be paid a $0.885 dividend. The ex-dividend date is Friday, June 28th. This represents a $3.54 dividend on an annualized basis and a yield of 1.01%. Humana’s dividend payout ratio is 22.04%.

Analyst Ratings Changes

A number of brokerages have weighed in on HUM. The Goldman Sachs Group lowered their price target on Humana from $450.00 to $385.00 and set a “buy” rating on the stock in a research report on Wednesday, April 3rd. Baird R W raised Humana to a “hold” rating in a research report on Thursday, May 30th. Robert W. Baird started coverage on Humana in a research report on Thursday, May 30th. They issued a “neutral” rating and a $374.00 target price on the stock. Oppenheimer decreased their target price on Humana from $415.00 to $370.00 and set an “outperform” rating on the stock in a research report on Thursday, April 25th. Finally, Wells Fargo & Company cut their price target on Humana from $413.00 to $350.00 and set an “overweight” rating for the company in a research note on Monday, April 8th. Thirteen investment analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company’s stock. Based on data from MarketBeat, Humana currently has an average rating of “Hold” and an average target price of $423.63.

Check Out Our Latest Stock Analysis on HUM

Humana Profile

(Free Report)

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.

Recommended Stories

Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc. (NYSE:HUMFree Report).

Institutional Ownership by Quarter for Humana (NYSE:HUM)

Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.